Payment overview · 2025
General Payments
$505.13
23 reported records · 11 companies
Healthcare provider profile · identity verified
Brian B Kimmel, DO
Allopathic & Osteopathic Physicians|Family Medicine · PHILADELPHIA, PA · NPI 1528007176
Verified facts
What the public records show
CMS Open Payments records show Brian B Kimmel, DO received $505.13 in general payments during 2025 across 23 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 19.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 14 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga, Nurtec Odt.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BEVESPI AEROSPHERE as an associated drug or biological on 763 records involving 473 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Bevespi Aerosphere by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 212 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 55 claims for Symbicort by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1795 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NURTEC ODT as an associated drug or biological on 217574 records involving 54025 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Nurtec Odt by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $97.59 | 19.3% | 5 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $76.01 | 15.1% | 4 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $73.52 | 14.6% | 4 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $43.83 | 8.7% | 1 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $43.33 | 8.6% | 2 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $34.72 | 6.9% | 2 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $33.27 | 6.6% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $32.77 | 6.5% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $26.76 | 5.3% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $25.38 | 5.0% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $17.95 | 3.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $505.13 | 23 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $130.36 | 6 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $59.02 | 3 | 2025 |
Source payment records
|
|||||
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $47.87 | 3 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $43.83 | 1 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $43.33 | 2 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $39.15 | 2 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $36.86 | 2 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $33.27 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26.76 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $25.65 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $25.38 | 1 | 2025 |
Source payment records
|
|||||
| VOWST Normalized: vowst |
Biological | Aimmune Therapeutics, Inc. | $19.21 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $17.95 | 1 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $15.51 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 212 | exact normalized | Medicare Part D |
| NURTEC ODT nurtec odt |
2025 | Nurtec Odt | 2024 | 12 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BEVESPI AEROSPHERE open payments reported associated product |
CMS Open Payments — General Payments 763 supporting records · 473 recipient NPIs · example record 1206131384 |
Bevespi Aerosphere · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
212 | 30 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
55 | 18 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1795 | 167 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | NURTEC ODT open payments reported associated product |
CMS Open Payments — General Payments 217574 supporting records · 54025 recipient NPIs · example record 1228794063 |
Nurtec Odt · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2737 | 461 |
| Eliquis | Apixaban | 1795 | 167 |
| Gabapentin | Gabapentin | 1755 | 240 |
| Amlodipine Besylate | Amlodipine Besylate | 1654 | 264 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1422 | 212 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1263 | 216 |
| Lisinopril | Lisinopril | 1190 | 184 |
| Furosemide | Furosemide | 1169 | 170 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1059 | 141 |
| Tamsulosin Hcl | Tamsulosin Hcl | 973 | 127 |
| Mirtazapine | Mirtazapine | 903 | 135 |
| Trazodone Hcl | Trazodone Hcl | 887 | 129 |
| Metformin Hcl | Metformin Hcl | 871 | 128 |
| Sertraline Hcl | Sertraline Hcl | 768 | 95 |
| Metoprolol Succinate | Metoprolol Succinate | 751 | 140 |
| Simvastatin | Simvastatin | 688 | 90 |
| Quetiapine Fumarate | Quetiapine Fumarate | 670 | 81 |
| Losartan Potassium | Losartan Potassium | 665 | 109 |
| Potassium Chloride | Potassium Chloride | 647 | 81 |
| Clopidogrel | Clopidogrel Bisulfate | 600 | 90 |
| Carvedilol | Carvedilol | 595 | 98 |
| Escitalopram Oxalate | Escitalopram Oxalate | 586 | 80 |
| Donepezil Hcl | Donepezil Hcl | 543 | 69 |
| Famotidine | Famotidine | 499 | 77 |
| Divalproex Sodium | Divalproex Sodium | 485 | 64 |
| Levetiracetam | Levetiracetam | 461 | 61 |
| Omeprazole | Omeprazole | 439 | 93 |
| Montelukast Sodium | Montelukast Sodium | 376 | 63 |
| Duloxetine Hcl | Duloxetine Hcl | 374 | 67 |
| Risperidone | Risperidone | 357 | 50 |
| Memantine Hcl | Memantine Hcl | 347 | 32 |
| Xarelto | Rivaroxaban | 317 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 291 | 64 |
| Buspirone Hcl | Buspirone Hcl | 289 | 38 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 287 | 107 |
| Hydralazine Hcl | Hydralazine Hcl | 281 | 58 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 280 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 269 | 63 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 251 | 33 |
| Lorazepam | Lorazepam | 246 | 54 |
| Latanoprost | Latanoprost | 241 | 54 |
| Nifedipine Er | Nifedipine | 241 | 45 |
| Baclofen | Baclofen | 236 | 36 |
| Aripiprazole | Aripiprazole | 234 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 232 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 230 | 51 |
| Finasteride | Finasteride | 228 | 38 |
| Allopurinol | Allopurinol | 227 | 34 |
| Lovastatin | Lovastatin | 215 | 22 |
| Warfarin Sodium | Warfarin Sodium | 215 | 16 |
| Farxiga | Dapagliflozin Propanediol | 212 | 30 |
| Tradjenta | Linagliptin | 208 | 21 |
| Midodrine Hcl | Midodrine Hcl | 207 | 45 |
| Amiodarone Hcl | Amiodarone Hcl | 199 | 37 |
| Januvia | Sitagliptin Phosphate | 193 | 19 |
| Tramadol Hcl | Tramadol Hcl | 191 | 46 |
| Glipizide | Glipizide | 183 | 28 |
| Olanzapine | Olanzapine | 177 | 24 |
| Atenolol | Atenolol | 173 | 27 |
| Novolog Flexpen | Insulin Aspart | 170 | 20 |
| Alendronate Sodium | Alendronate Sodium | 169 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 169 | 33 |
| Fluoxetine Hcl | Fluoxetine Hcl | 169 | 24 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 168 | 23 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 167 | 60 |
| Myrbetriq | Mirabegron | 167 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 165 | 68 |
| Meloxicam | Meloxicam | 165 | 28 |
| Clozapine | Clozapine | 163 | 11 |
| Ibuprofen | Ibuprofen | 162 | 36 |
| Breo Ellipta | Fluticasone/Vilanterol | 158 | 28 |
| Paroxetine Hcl | Paroxetine Hcl | 154 | 21 |
| Entresto | Sacubitril/Valsartan | 153 | 17 |
| Lactulose | Lactulose | 153 | 23 |
| Prednisone | Prednisone | 149 | 46 |
| Spironolactone | Spironolactone | 148 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 144 | 25 |
| Clonazepam | Clonazepam | 141 | 32 |
| Enoxaparin Sodium | Enoxaparin Sodium | 139 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 139 | 38 |
| Tizanidine Hcl | Tizanidine Hcl | 133 | 28 |
| Alprazolam | Alprazolam | 131 | 26 |
| Ezetimibe | Ezetimibe | 131 | 29 |
| Bumetanide | Bumetanide | 130 | 29 |
| Benztropine Mesylate | Benztropine Mesylate | 128 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 123 | 27 |
| Hydrocortisone | Hydrocortisone | 123 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 120 | 67 |
| Diltiazem Hcl | Diltiazem Hcl | 116 | 14 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 115 | 36 |
| Jardiance | Empagliflozin | 107 | 20 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 107 | 32 |
| Xifaxan | Rifaximin | 107 | 11 |
| Lamotrigine | Lamotrigine | 106 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 105 | 31 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 102 | 26 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 100 | 20 |
| Divalproex Sodium Er | Divalproex Sodium | 98 | 12 |
| Trulicity | Dulaglutide | 96 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 92 | 16 |
| Metformin Hcl Er | Metformin Hcl | 88 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 88 | 23 |
| Incruse Ellipta | Umeclidinium Bromide | 87 | 17 |
| Amantadine | Amantadine Hcl | 85 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 85 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 84 | 16 |
| Pregabalin | Pregabalin | 84 | 21 |
| Vascepa | Icosapent Ethyl | 84 | 11 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 83 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 83 | 37 |
| Dicyclomine Hcl | Dicyclomine Hcl | 81 | 17 |
| Azithromycin | Azithromycin | 80 | 58 |
| Brimonidine Tartrate | Brimonidine Tartrate | 80 | 17 |
| Nystatin | Nystatin | 79 | 36 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 79 | 77 |
| Sucralfate | Sucralfate | 79 | 12 |
| Albuterol Sulfate | Albuterol Sulfate | 76 | 31 |
| Clonidine Hcl | Clonidine Hcl | 73 | 14 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 73 | 15 |
| Torsemide | Torsemide | 73 | 16 |
| Ventolin Hfa | Albuterol Sulfate | 73 | 31 |
| Doxepin Hcl | Doxepin Hcl | 71 | suppressed |
| Valsartan | Valsartan | 68 | suppressed |
| Bupropion Xl | Bupropion Hcl | 67 | 11 |
| Cephalexin | Cephalexin | 67 | 54 |
| Glimepiride | Glimepiride | 67 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 62 | 12 |
| Insulin Lispro | Insulin Lispro | 62 | 24 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 62 | 27 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 62 | 11 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 61 | 13 |
| Santyl | Collagenase Clostridium Hist. | 61 | 30 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 59 | suppressed |
| Ketoconazole | Ketoconazole | 59 | 21 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 59 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 55 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 55 | 18 |
| Humalog Kwikpen U-100 | Insulin Lispro | 54 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 53 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 52 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 51 | 13 |
| Celecoxib | Celecoxib | 51 | 12 |
| Chlorthalidone | Chlorthalidone | 51 | suppressed |
| Digoxin | Digoxin | 51 | suppressed |
| Methylprednisolone | Methylprednisolone | 51 | 18 |
| Nystop | Nystatin | 51 | 30 |
| Venlafaxine Hcl | Venlafaxine Hcl | 50 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 49 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 49 | suppressed |
| Gemtesa | Vibegron | 49 | suppressed |
| Admelog | Insulin Lispro | 48 | suppressed |
| Lansoprazole | Lansoprazole | 48 | suppressed |
| Linzess | Linaclotide | 48 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 48 | 16 |
| Methimazole | Methimazole | 48 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 48 | suppressed |
| Estradiol | Estradiol | 47 | suppressed |
| Timolol Maleate | Timolol Maleate | 47 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 46 | 36 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 46 | 26 |
| Lacosamide | Lacosamide | 45 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 44 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 43 | 34 |
| Topiramate | Topiramate | 43 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 42 | suppressed |
| Haloperidol | Haloperidol | 42 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 42 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 42 | suppressed |
| Fenofibrate | Fenofibrate | 41 | suppressed |
| Lidocaine | Lidocaine | 41 | 13 |
| Naproxen | Naproxen | 41 | 14 |
| Sulfasalazine | Sulfasalazine | 41 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 40 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 40 | 20 |
| Spiriva Handihaler | Tiotropium Bromide | 40 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 40 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 39 | suppressed |
| Diazepam | Diazepam | 39 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 39 | suppressed |
| Methotrexate | Methotrexate Sodium | 39 | suppressed |
| Novolog | Insulin Aspart | 39 | 12 |
| Repaglinide | Repaglinide | 39 | suppressed |
| Carbamazepine | Carbamazepine | 38 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 38 | 29 |
| Dutasteride | Dutasteride | 38 | suppressed |
| Glipizide Er | Glipizide | 38 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 38 | suppressed |
| Mresvia | Rsv Vaccine, Pref, Mrna/Pf | 38 | 38 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 37 | 30 |
| Levofloxacin | Levofloxacin | 36 | 27 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 36 | 13 |
| Sotalol | Sotalol Hcl | 36 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 35 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 35 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 35 | 24 |
| Ammonium Lactate | Ammonium Lactate | 34 | 21 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 34 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 34 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 34 | suppressed |
| Anastrozole | Anastrozole | 33 | suppressed |
| Scopolamine | Scopolamine | 33 | suppressed |
| Temazepam | Temazepam | 33 | suppressed |
| Cilostazol | Cilostazol | 32 | suppressed |
| Loperamide | Loperamide Hcl | 32 | 22 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 32 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 31 | suppressed |
| Mupirocin | Mupirocin | 31 | 20 |
| Phenobarbital | Phenobarbital | 31 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 31 | suppressed |
| Clonidine | Clonidine | 30 | suppressed |
| Clotrimazole | Clotrimazole | 30 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 30 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 30 | 12 |
| Dapagliflozin | Dapagliflozin Propanediol | 29 | 14 |
| Labetalol Hcl | Labetalol Hcl | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | 12 |
| Spiriva Respimat | Tiotropium Bromide | 29 | 11 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 28 | 12 |
| Haloperidol Lactate | Haloperidol Lactate | 28 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 28 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 28 | 22 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 28 | suppressed |
| Clozapine Odt | Clozapine | 27 | suppressed |
| Erythromycin | Erythromycin Base | 27 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 27 | suppressed |
| Amoxicillin | Amoxicillin | 26 | 19 |
| Elmiron | Pentosan Polysulfate Sodium | 26 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Budesonide | Budesonide | 25 | suppressed |
| Carbamazepine Er | Carbamazepine | 25 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 25 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 25 | suppressed |
| Klayesta | Nystatin | 25 | 11 |
| Valacyclovir | Valacyclovir Hcl | 25 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | 11 |
| Flecainide Acetate | Flecainide Acetate | 24 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 24 | 13 |
| Nortriptyline Hcl | Nortriptyline Hcl | 24 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Ramipril | Ramipril | 24 | suppressed |
| Verapamil Er | Verapamil Hcl | 24 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 23 | suppressed |
| Nitroglycerin | Nitroglycerin | 23 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 23 | suppressed |
| Azathioprine | Azathioprine | 22 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 22 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 22 | suppressed |
| Metolazone | Metolazone | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 21 | suppressed |
| Insulin Aspart Prot Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 21 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 20 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 20 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 20 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 20 | suppressed |
| Nyamyc | Nystatin | 20 | 14 |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 19 | suppressed |
| Calcium Acetate | Calcium Acetate | 19 | suppressed |
| Propylthiouracil | Propylthiouracil | 19 | suppressed |
| Alogliptin | Alogliptin Benzoate | 18 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 18 | 11 |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Dexamethasone | Dexamethasone | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Lorazepam Intensol | Lorazepam | 18 | 14 |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Humalog | Insulin Lispro | 17 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 17 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 17 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 17 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 17 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 17 | suppressed |
| Zonisamide | Zonisamide | 17 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 16 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 16 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 16 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 15 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 15 | suppressed |
| Jantoven | Warfarin Sodium | 15 | suppressed |
| Ramelteon | Ramelteon | 15 | suppressed |
| Rhopressa | Netarsudil Mesylate | 15 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 15 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 15 | suppressed |
| Tivicay | Dolutegravir Sodium | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 14 | 13 |
| Desmopressin Acetate | Desmopressin Acetate | 14 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 14 | 12 |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 14 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 14 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 14 | suppressed |
| Ofloxacin | Ofloxacin | 14 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Klor-Con 10 | Potassium Chloride | 13 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 13 | 13 |
| Mirabegron Er | Mirabegron | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 13 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 13 | suppressed |
| Acetylcysteine | Acetylcysteine | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 12 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 12 | suppressed |
| Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 12 | suppressed |
| Briviact | Brivaracetam | 12 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 12 | suppressed |
| Carbatrol | Carbamazepine | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Cyclosporine | Cyclosporine | 12 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 12 | suppressed |
| Fluocinonide | Fluocinonide | 12 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 12 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 12 | suppressed |
| Renvela | Sevelamer Carbonate | 12 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 12 | suppressed |
| Vraylar | Cariprazine Hcl | 12 | suppressed |
| Acetazolamide | Acetazolamide | 11 | suppressed |
| Acetazolamide Er | Acetazolamide | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 11 | suppressed |
| Drizalma Sprinkle | Duloxetine Hcl | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 11 | suppressed |
| Indapamide | Indapamide | 11 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 11 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 11 | suppressed |
| Nateglinide | Nateglinide | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
| Restasis Multidose | Cyclosporine | 11 | suppressed |
| Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $505.13 · 23 records | Otsuka America Pharmaceutical, Inc. | AIRSUPRA, CAPLYTA, Cologuard Collection Kit, Dexcom G6 Transmitter, FARXIGA, Kerendia, NUPLAZID, NURTEC ODT, PAXLOVID, REPATHA, REXULTI, VOWST, ZAVZPRET, ZENPEP | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error